Elena J Tucker

Dr. Elena J Tucker

Murdoch Childrens Research Institute, MCRI. Department of Paediatrics, University of Melbourne, Parkville VIC 3010, Australia
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2012 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
SCSarah E. Calvo
Sarah E. Calvo
ACAlison G Compton
Alison G Compton
SHSteven G. Hershman
Steven G. Hershman
SLSze Chern Lim
Sze Chern Lim
DLDaniel S. Lieber
Daniel S. Lieber
VMVamsi K. Mootha
Vamsi K. Mootha
Advances in next-generation sequencing (NGS) promise to facilitate diagnosis of inherited disorders. Although in research settings NGS has pinpointed causal alleles using segregation in large families, the key challenge for clinical diagnosis is application to single individuals. To explore its diagnostic use, we performed targeted NGS in 42 unrelated infants with clinical and biochemical evidence of mitochondrial oxidative phosphorylation disease. These devastating mitochondrial disorders are characterized by phenotypic and genetic heterogeneity, with more than 100 causal genes identified to date. We performed “MitoExome” sequencing of the mitochondrial DNA (mtDNA) and exons of ~1000 nuclear genes encoding mitochondrial proteins and prioritized rare mutations predicted to disrupt function. Because patients and healthy control individuals harbored a comparable number of such heterozygous alleles, we could not prioritize dominant-acting genes. However, patients showed a fivefold enrichment of genes with two such mutations that could underlie recessive disease. In total, 23 of 42 (55%) patients harbored such recessive genes or pathogenic mtDNA variants. Firm diagnoses were enabled in 10 patients (24%) who had mutations in genes previously linked to disease. Thirteen patients (31%) had mutations in nuclear genes not previously linked to disease. The pathogenicity of two such genes, NDUFB3 and AGK, was supported by complementation studies and evidence from multiple patients, respectively. The results underscore the potential and challenges of deploying NGS in clinical settings.

5 September 2010 in Nature Genetics
Verified
Journal Article
Open access
PDF file
SCSarah E Calvo
Sarah E Calvo
ETElena J Tucker
Elena J Tucker
ACAlison G Compton
Alison G Compton
DKDenise M Kirby
Denise M Kirby
GCGabriel Crawford
Gabriel Crawford
VMVamsi K Mootha
Vamsi K Mootha
Vamsi Mootha and colleagues report high-throughput targeted sequencing of 103 candidate genes in 103 individuals with human mitochondrial complex I deficiency. They identify two genes newly associated with complex I deficiency and are able to provide genetic diagnoses in 22% of their previously unsolved cases. Discovering the molecular basis of mitochondrial respiratory chain disease is challenging given the large number of both mitochondrial and nuclear genes that are involved. We report a strategy of focused candidate gene prediction, high-throughput sequencing and experimental validation to uncover the molecular basis of mitochondrial complex I disorders. We created seven pools of DNA from a cohort of 103 cases and 42 healthy controls and then performed deep sequencing of 103 candidate genes to identify 151 rare variants that were predicted to affect protein function. We established genetic diagnoses in 13 of 60 previously unsolved cases using confirmatory experiments, including cDNA complementation to show that mutations in NUBPL and FOXRED1 can cause complex I deficiency. Our study illustrates how large-scale sequencing, coupled with functional prediction and experimental validation, can be used to identify causal mutations in individual cases.

3 October 2016 in Endocrine Reviews
Verified
Journal Article
Closed access
PDF file
ETElena J Tucker
Elena J Tucker
SGSonia R. Grover
Sonia R. Grover
ABAnne Bachelot
Anne Bachelot
PTPhilippe Touraine
Philippe Touraine
ASAndrew H. Sinclair
Andrew H. Sinclair
Premature ovarian insufficiency (POI) is one form of female infertility, defined by loss of ovarian activity before the age of 40 and characterized by amenorrhea (primary or secondary) with raised gonadotropins and low estradiol. POI affects up to one in 100 females, including one in 1000 before the age of 30. Substantial evidence suggests a genetic basis for POI; however, the majority of cases remain unexplained, indicating that genes likely to be associated with this condition are yet to be discovered. This review discusses the current knowledge of the genetic basis of POI. We highlight genes typically known to cause syndromic POI that can be responsible for isolated POI. The role of mouse models in understanding POI pathogenesis is discussed, and a thorough list of candidate POI genes is provided. Identifying a genetic basis for POI has multiple advantages, such as enabling the identification of presymptomatic family members who can be offered counseling and cryopreservation of eggs before depletion, enabling personalized treatment based on the cause of an individual's condition, and providing better understanding of disease mechanisms that ultimately aid the development of improved treatments.

1 September 2011 in Cell Metabolism
Verified
Journal Article
Closed access
ETElena J Tucker
Elena J Tucker
SHSteven G. Hershman
Steven G. Hershman
CKCaroline Köhrer
Caroline Köhrer
CBCasey A. Belcher-Timme
Casey A. Belcher-Timme
JPJinal Patel
Jinal Patel
VMVamsi K. Mootha
Vamsi K. Mootha

24 May 2017 in Brain
Verified
Journal Article
Open access
PDF file
RDRadha Desai
Radha Desai
AFAnn Frazier
Ann Frazier
RDRomina Durigon
Romina Durigon
HPHarshil Patel
Harshil Patel
AJAleck W. Jones
Aleck W. Jones
ASAntonella Spinazzola
Antonella Spinazzola
Although mitochondrial disorders are clinically heterogeneous, they frequently involve the central nervous system and are among the most common neurogenetic disorders. Identifying the causal genes has benefited enormously from advances in high-throughput sequencing technologies; however, once the defect is known, researchers face the challenge of deciphering the underlying disease mechanism. Here we characterize large biallelic deletions in the region encoding the ATAD3C, ATAD3B and ATAD3A genes. Although high homology complicates genomic analysis of the ATAD3 defects, they can be identified by targeted analysis of standard single nucleotide polymorphism array and whole exome sequencing data. We report deletions that generate chimeric ATAD3B/ATAD3A fusion genes in individuals from four unrelated families with fatal congenital pontocerebellar hypoplasia, whereas a case with genomic rearrangements affecting the ATAD3C/ATAD3B genes on one allele and ATAD3B/ATAD3A genes on the other displays later-onset encephalopathy with cerebellar atrophy, ataxia and dystonia. Fibroblasts from affected individuals display mitochondrial DNA abnormalities, associated with multiple indicators of altered cholesterol metabolism. Moreover, drug-induced perturbations of cholesterol homeostasis cause mitochondrial DNA disorganization in control cells, while mitochondrial DNA aggregation in the genetic cholesterol trafficking disorder Niemann-Pick type C disease further corroborates the interdependence of mitochondrial DNA organization and cholesterol. These data demonstrate the integration of mitochondria in cellular cholesterol homeostasis, in which ATAD3 plays a critical role. The dual problem of perturbed cholesterol metabolism and mitochondrial dysfunction could be widespread in neurological and neurodegenerative diseases.

12 September 2024 in Nature Reviews Disease Primers
Verified
Journal Article
Closed access
PDF file
PTPhilippe Touraine
Philippe Touraine
NCNathalie Chabbert-Buffet
Nathalie Chabbert-Buffet
GPGenevieve Plu-Bureau
Genevieve Plu-Bureau
LDLise Duranteau
Lise Duranteau
ASAndrew H. Sinclair
Andrew H. Sinclair
ETElena J Tucker
Elena J Tucker